King's College Hospital
London, SE5 9RS, United Kingdom
NCT Number: NCT03736551
This study proposes to investigate the acceptability and efficacy of intermittent VLED (5:2 diet) plus exercise, compared with the investigator's established Weight Management Programme (WMP), in obese patients with CKD, using feasibility study methodology.
Patients will be invited to participate in the parallel arm, single blinded, randomised controlled feasibility study, and randomly allocated to 1 of 2 treatments for 6 months. The experimental arm involves an intermittent modified fasting regimen consisting of VLED (600 kcal/day) on 2 consecutive days, and 5 days each week on a modified diet to maintain an overall energy deficit of 600 kcal/day across the week (5:2 diet). The control arm will be the standard renal WMP with a continuous energy restricted diet aimed at reducing daily energy intake by 600 kcal/day.
The feasibility outcomes are: recruitment rate >50%; intervention retention rate at 6 months >60%; dietary intervention compliance; and weight loss. Secondary outcomes include safety, body composition, proteinuria, lipids, blood pressure, and eating desire. Measurements will be made at baseline, midpoint, and twice at endpoint.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
London, SE5 9RS, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
very low energy diet (600 kcal/day) on 2 consecutive days of the week, and 5 days each week on an energy restricted diet to maintain a similar overall energy deficit of 600 kcal/day across the week (5:2 diet)
Dietary intervention includes a standard continuous energy restricted diet aimed at reducing daily energy intake by 600 kcal/day relative to their estimated total energy expenditure. In addition to the dietary intervention, the programme also includes personal exercise plans, optional pharmacotherapy (orlistat at standard dose), and development of personalised dietary and exercise goals using behavioural therapy techniques and motivational interviewing.
Time frame: 6 months
Patients attending at least 80% of monthly clinic visits, including the baseline and final study visits, and remaining compliant with the 2 consecutive days VLED throughout the 6 month intervention will be considered "completers" and count as being retained in the intervention group at 6 months.
Time frame: 6 months
record of all adverse events including but not limited to nausea, constipation and/or diarrhoea, dehydration, hypoglycaemia, lethargy & fatigue, headaches, gallstones and gout.
Time frame: 1 year
at least 50% of those meeting the referral criteria and are approached to participant, consent to participating in the study
Time frame: 6 months
at least 70% compliance with prescribed diet
Time frame: 6 months
change in weight from baseline to 6 months
Time frame: 6 months
monitoring if estimated kidney function declines during the study or if symptomatic for dehydration.
Time frame: 6 months
change in waist circumference measured in cm at level of umbilicus
Time frame: 6 months
lean and fat mass (kg) estimated by bioelectrical impedance analysis
Time frame: 6 months
distance walked (m) in 6 minutes
Time frame: 6 months
number (count) of sit to stand movements in 60 seconds
Time frame: 6 months
urinary protein to creatinine ratio
Time frame: 6 months
plasma total cholesterol concentration
Time frame: 6 months
plasma triglycerides concentration
Time frame: 6 months
plasma LDL cholesterol concentration
Time frame: 6 months
plasma HDL cholesterol concentration
King's College Hospital NHS Trust
Other
Model of Intermittent Very Low Energy Diet and eXercise for Lowering BMI in Patients With CKD (MIX UP): Feasibility Study
Acronym: MIX-UP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04761016
Body Weight, Cardiovascular Diseases
Dallas, Texas, United States
View Trial DetailsNCT02950142
Acute Coronary Syndrome, Anemia
Leuven, Belgium
View Trial DetailsNCT03285074
Body Weight, Chronic Disease
View Trial DetailsNCT05173714
Body Weight, Chronic Disease
Stanford, California, United States
View Trial Details